Transplantation of Nurr1‐overexpressing neural stem cells and microglia for treating parkinsonian rats

Background Neural stem cells (NSCs) transplantation is considered a promising treatment for Parkinson's disease. But most NSCs are differentiated into glial cells rather than neurons, and only a few of them survive after transplantation due to the inflammatory environment. Methods In this study...

Full description

Saved in:
Bibliographic Details
Published inCNS neuroscience & therapeutics Vol. 26; no. 1; pp. 55 - 65
Main Authors Qian, Yuan, Chen, Xiao‐Xiang, Wang, Wei, Li, Jun‐Jun, Wang, Xian‐Peng, Tang, Zhi‐Wei, Xu, Jiao‐Tian, Lin, Hai, Yang, Zhi‐Yong, Li, Li‐Yan, Song, Xiao‐Bin, Guo, Jia‐Zhi, Bian, Li‐Gong, Zhou, Lei, Lu, Di, Deng, Xing‐Li
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.01.2020
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Neural stem cells (NSCs) transplantation is considered a promising treatment for Parkinson's disease. But most NSCs are differentiated into glial cells rather than neurons, and only a few of them survive after transplantation due to the inflammatory environment. Methods In this study, neural stem cells (NSCs) and microglial cells both forced with the Nurr1 gene were transplanted into the striatum of the rat model of PD. The results were evaluated through reverse transcription polymerase chain reaction (RT‐PCR), Western blot, and immunofluorescence analysis. Results The behavioral abnormalities of PD rats were improved by combined transplantation of NSCs and microglia, both forced with Nurr1. The number of tyrosine hydroxylase+ cells in the striatum of PD rats increased, and the number of Iba1+ cells decreased compared with the other groups. Moreover, the dopamine neurons differentiated from grafted NSCs could still be detected in the striatum of PD rats after 5 months. Conclusions The results suggested that transplantation of Nurr1‐overexpressing NSCs and microglia could improve the inhospitable host brain environments, which will be  a new potential strategy for the cell replacement therapy in PD.
Bibliography:Funding information
Data Availability Statement
All data generated or analyzed during this study are included in this published article.
This work was supported by the grants from the National Natural Sciences Foundation of China (81241126 and 81360197), the Department of Science and Technology of Yunnan Province (2013C227), the Joint Special Funds for the Department of Science and Technology of Yunnan Province–Kunming Medical University (2014FB041).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Data Availability Statement: All data generated or analyzed during this study are included in this published article.
Qian and Chen are contributed equally to this work.
ISSN:1755-5930
1755-5949
DOI:10.1111/cns.13149